PAVmed (PAVMZ) Institutional Ownership → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free PAVMZ Stock Alerts $0.03 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for PAVmed (NASDAQ:PAVMZ)Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$25.76K Get PAVMZ Insider Trade Alerts Want to know when executives and insiders are buying or selling PAVmed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… PAVmed Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/25/2023 Raymond James & Associates174,542$28K0.0%-48.0%0.000% (Data available from 1/1/2016 forward) PAVMZ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PAVMZ shares? During the previous two years, the following institutional investors and hedge funds held shares of PAVmed shares: Raymond James & Associates ($28K).Learn more on PAVMZ's institutional investors. Which PAVmed major shareholders have been selling company stock? The following institutional investors have sold PAVmed stock in the last 24 months: Raymond James & Associates ($160.99K). How much institutional selling is happening at PAVmed? Institutional investors have sold a total of 160,994 shares in the last 24 months. This volume of shares sold represents approximately $25.76K in transactions. Related Companies: Heart Test Laboratories Major Shareholders TriSalus Life Sciences Major Shareholders Alpha Tau Medical Major Shareholders Alvotech Major Shareholders American Oncology Network Major Shareholders Apollomics Major Shareholders BriaCell Therapeutics Major Shareholders Bullfrog AI Major Shareholders Cardio Diagnostics Major Shareholders Celularity Major Shareholders This page (NASDAQ:PAVMZ) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryObama’s Forever Term [exposed]Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
